MEDIKAMENT TIL BEHANDLING AF INFEKTIONSSYGDOMME
This invention relates to the field of medicine, particularly to a medicament for treating bacterial infections, which presents a technology-processed product resulting from multiple serial dilutions of the stock substances of antibodies to HLA-DRB1 and antibodies to β2-microglobulin, and to a combi...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | dan |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to the field of medicine, particularly to a medicament for treating bacterial infections, which presents a technology-processed product resulting from multiple serial dilutions of the stock substances of antibodies to HLA-DRB1 and antibodies to β2-microglobulin, and to a combination of the claimed medicament with antibiotic, to a method of treating bacterial infections, a method of reducing bacterial resistance to antibiotic therapy and a method of enhancing antibiotic efficacy. Besides, this invention relates to a medicament for treating infectious diseases, which exerts antibacterial and antiviral effects and presents a technology-processed product resulting from multiple serial dilutions of the stock substances of a) antibodies to HLA-DRB1, b) antibodies to β2-MG, c) antibodies to IFN-γ and d) antibodies to CD4. This invention ensures an effective treatment of infectious diseases, decreases resistance to antibiotics, enhances the therapeutic efficacy of antibiotics, including efficacy against resistant bacteria, and reduces effective doses of antibiotics. |
---|